z-logo
open-access-imgOpen Access
Should paclitaxel be considered an old generation DCB? The limus era
Author(s) -
Gaetano Di Palma,
Erick Sanchez-Jimenez,
Florin-Leontin Lazăr,
Bernardo Cortese
Publication year - 2021
Publication title -
reviews in cardiovascular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.555
H-Index - 39
eISSN - 2153-8174
pISSN - 1530-6550
DOI - 10.31083/j.rcm2204138
Subject(s) - paclitaxel , medicine , cath lab , restenosis , sirolimus , safety profile , surgery , stent , intensive care medicine , pharmacology , chemotherapy , adverse effect , myocardial infarction , conventional pci

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom